Showing 221-230 of 756 results for "".
Rituximab-induced Serum Sickness in Pemphigus Vulgaris: A Case Report and Literature Review
https://practicaldermatology.com/youngmd-connect/resident-resource-center/rituximab-induced-serum-sickness-in-pemphigus-vulgaris-a-case-report-and-literature-review/20808/Having an Ethical Relationship With Industry
https://practicaldermatology.com/topics/practice-management/having-an-ethical-relationship-with-industry/23965/Navigating a shifting landscape: How to keep it ethical with industry relations.The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/the-heart-of-the-matter/21043/American heart month—celebrated in February—calls attention to link between psoriasis and CV disease.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.2024 In Review: This Year's Trends in Dermatology
https://practicaldermatology.com/topics/feature/2024-review-years-trends-dermatology/29886/As the year comes to a close, Practical Dermatology asked Editorial Board members about trends from 2024—what was hot, what was not, new approvals that lived up to the hype, important new research, and other observations from the past year.Currents: Skin Cancer Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-skin-cancer-update/23259/Currents
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents/20991/The Penalty Era: The Next Phase in Medicine
https://practicaldermatology.com/topics/practice-management/the-penalty-era-the-next-phase-in-medicine/21159/New proposed rule changes spell an uncertain future for the Meaningful Use program.Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/